AI assistant
Sending…
FENNEC PHARMACEUTICALS INC. — Director's Dealing 2026
Mar 3, 2026
35599_dirs_2026-03-03_b8f7a268-8a72-47c4-b9b0-9e9867e22830.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2026-02-28
Reporting Person: Andrade Robert (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-02-28 | Common shares | A | 1191 | — | Acquired | 243584 | Direct |
Footnotes
F1: Represents shares released from restriction from shares awarded 3/31/2023 and 5/16/2024.
More from FENNEC PHARMACEUTICALS INC.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 7
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 20
Director's Dealing
2026
Feb 20